Biofrontera Inc. (BFRIW) stock
BFRIWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BFRI
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/30
$0.00+0.00 (0.00%)
Close on Oct 30, 2026Market cap $12.96MP/E –Yield –
Biofrontera profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Biofrontera's profit margin for the twelve months ending Jun 30, 2026 was -13.8%. For fiscal 2025 it was -25.3%, against -47.6% the year before. The highest annual figure on record is -2.2% in fiscal 2022.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -25.3% | +22.3 |
| FY2024 | Dec 31, 2024 | -47.6% | +11.5 |
| FY2023 | Dec 31, 2023 | -59.1% | −56.9 |
| FY2022 | Dec 31, 2022 | -2.2% | +154.3 |
| FY2021 | Dec 31, 2021 | -156.5% | −98.2 |
| FY2020 | Dec 31, 2020 | -58.3% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -5.0% | +53.9 |
| Q1 FY2026 | Mar 31, 2026 | -47.1% | +1.8 |
| Q4 FY2025 | Dec 31, 2025 | 33.0% | +44.1 |
| Q3 FY2025 | Sep 30, 2025 | -95.1% | −32.2 |
| Q2 FY2025 | Jun 30, 2025 | -59.0% | −55.7 |
| Q1 FY2025 | Mar 31, 2025 | -48.9% | +83.0 |
| Q4 FY2024 | Dec 31, 2024 | -11.1% | −44.4 |
| Q3 FY2024 | Sep 30, 2024 | -62.9% | +8.4 |
| Q2 FY2024 | Jun 30, 2024 | -3.3% | +164.9 |
| Q1 FY2024 | Mar 31, 2024 | -131.9% | −46.3 |
| Q4 FY2023 | Dec 31, 2023 | 33.3% | +60.7 |
| Q3 FY2023 | Sep 30, 2023 | -71.3% | −11.9 |
| Q2 FY2023 | Jun 30, 2023 | -168.2% | −149.1 |
| Q1 FY2023 | Mar 31, 2023 | -85.6% | −142.7 |
| Q4 FY2022 | Dec 31, 2022 | -27.5% | +130.8 |
| Q3 FY2022 | Sep 30, 2022 | -59.4% | +310.1 |
| Q2 FY2022 | Jun 30, 2022 | -19.1% | +43.5 |
| Q1 FY2022 | Mar 31, 2022 | 57.0% | +131.5 |
| Q4 FY2021 | Dec 31, 2021 | -158.2% | −156.0 |
| Q3 FY2021 | Sep 30, 2021 | -369.5% | −277.7 |
| Q2 FY2021 | Jun 30, 2021 | -62.5% | – |
| Q1 FY2021 | Mar 31, 2021 | -74.5% | – |
| Q4 FY2020 | Dec 31, 2020 | -2.2% | – |
| Q3 FY2020 | Sep 30, 2020 | -91.8% | – |